文献速递乳腺癌

三阴性乳腺癌淋巴结免疫分析揭示TILs高低与免疫检查点表达差异

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.
PubMed 文献 · Eur J Cancer · 2021-03-17

该研究比较了15例高TILs(≥50%)和20例低TILs(≤5%)的局部三阴性乳腺癌患者淋巴结中五种免疫检查点的蛋白表达,并进行免疫基因表达谱和全外显子测序分析。低TILs患者淋巴结中CTLA-4表达更高,且肿瘤新生抗原负荷及B7.H3、B7.H4表达更高;高TILs患者肿瘤细胞PD-L1阳性更多且体液免疫应答更扩展。结果提示逆转低肿瘤免疫浸润的策略。

要点

  • 低TILs三阴性乳腺癌患者局部淋巴结CTLA-4表达升高,可能与淋巴细胞滞留有关。
  • 低TILs患者肿瘤新生抗原负荷及B7.H3、B7.H4表达更高。
  • 高TILs患者肿瘤细胞PD-L1阳性更多且体液免疫应答更扩展。

核心结论

  • 低TILs三阴性乳腺癌患者局部淋巴结CTLA-4高表达可能解释淋巴细胞滞留,高TILs患者则表现为更多PD-L1+肿瘤细胞和扩展的体液免疫应答。

研究设计与样本

  • 研究纳入15例高TILs(≥50%)和20例低TILs(≤5%)的局部三阴性乳腺癌患者(T1c-T2N0M0),比较淋巴结中五种免疫检查点蛋白表达,并行定制50免疫基因NanoString表达谱、NanoString 360乳腺癌panel及全外显子测序分析突变和新生抗原负荷。

主要发现

  • 低TILs患者局部淋巴结CTLA-4表达更高,肿瘤新生抗原负荷及B7.H3、B7.H4表达更高。
  • 高TILs患者肿瘤细胞PD-L1阳性更多,体液免疫应答更扩展。

临床怎么用

  • 结果提示可针对低TILs三阴性乳腺癌患者淋巴结免疫检查点(如CTLA-4)设计策略以逆转低肿瘤免疫浸润、改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with unmet medical needs. Several studies have proved that high levels of tumor infiltrating lymphocytes (TILs) at diagnosis of TNBC confer better prognosis and patients respond better to specific chemotherapies. Nonetheless, current evidence suggests that only 15% of TNBC patients have very high levels of TILs, and another 15% lacks TILs. One possible reason to explain why patients have low TILs at diagnosis is that lymphocytes might be deactivated by an immune checkpoint in local lymph nodes, provoking their retention in there as they are unresponsive to other immune stimuli. We have identified 15 high TILs (≥50%) and 20 low TILs (≤5%) TNBC patients with localised tumour (T1c-T2N0M0) and compared the protein expression of five immune checkpoints in lymph nodes. We have also performed a customised 50-immune gene NanoString expression panel, the NanoString 360 Breast Cancer panel, and whole exome sequencing for mutation and neoantigen load analyses. In low TILs, we observed higher expression of CTLA-4 in local lymph nodes, which could explain why lymphocytes get retained in there and do not migrate to tumour. These patients have also higher neoantigen load and higher expression of B7.H3 and B7.H4 in the tumour. In high TILs, we observed more PD-L1+ tumour cells and more expanded humoral response. These results could provide a strategy to revert low tumour immune infiltration at diagnosis of TNBC, improving their prognosis.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Quintana Á, Peg V, Prat A, et al. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer. Eur J Cancer. 2021. PMID: 33743482. doi:10.1016/j.ejca.2021.01.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。